Efficacy of metformin supplementation during ovarian stimulation of lean PCOS patients undergoing in vitro fertilization

References

• Dunaif A, Graf M, Mandeli J, Laumas V, Dobrjansky A. Characterization of groups of hyperandrogenic women with acanthosis nigricans, impaired glucose tolerance, and/or hyperinsulinemia. J Clin Endocrinol Metab. 1987; 65: 499–507
   PubMed Web of Science ®Google Scholar
• Knochenhauer ES, Key TJ, Kahsar-Miller M, Waggoner W, Boots LR, Azziz R. Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study. J Clin Endocrinol Metab. 1998; 83: 3078–82
   PubMed Web of Science ®Google Scholar
• Rotterdam ESHRE/ASRM-sponsored Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod. 2004;19:41–7.
   PubMed Web of Science ®Google Scholar
• Utiger RD. Insulin and the polycystic ovary syndrome. N Engl J Med. 1996; 335: 657–8
   PubMed Web of Science ®Google Scholar
• Franks S, Gharani N, McCarthy M. Genetic abnormalities in polycystic ovary syndrome. Ann Endocrinol. 1999; 60: 131–3
   PubMed Web of Science ®Google Scholar
• Dunaif A. Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocr Rev. 1997; 18: 774–800
   PubMed Web of Science ®Google Scholar
• Frank S. Polycystic ovary syndrome: a changing perspective. Clin Endocrinol. 1989; 31: 87–120
   PubMed Web of Science ®Google Scholar
• Nestler JE. Polycystic ovary syndrome: a disorder for the generalist. Fertil Steril. 1998; 70: 811–2
   PubMed Web of Science ®Google Scholar
• Bailey CJ, Turner RC. Metformin. N Eng J Med. 1996; 334: 574–9
   PubMed Web of Science ®Google Scholar
• Pryor PR, Liu SC, Clark AE, Yang J, Holman GD, Tosh D. Chronic insulin effects on insulin signalling and GLUT4 endocytosis are reversed by metformin. Biochem J. 2000; 348: 83–91
   PubMed Web of Science ®Google Scholar
• Legro RS, Myers E. Surrogate end-points or primary outcomes in clinical trials in women with polycystic ovary syndrome?. Hum Reprod. 2004; 19: 1697–704
   PubMed Web of Science ®Google Scholar
• Dunaif A, Segal KR, Futterweit W, Dobrjansky A. Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome. Diabetes. 1989; 38: 1165–74
   PubMed Web of Science ®Google Scholar
• Velazquez EM, Mendoza S, Hamer T, Saso F, Glueck CJ. Metformin therapy in polycystic ovary syndrome reduces hyperinsulinemia, insulin resistance, hyperandrogenemia, and systolic blood pressure, while facilitating normal menses and pregnancy. Metabolism. 1994; 43: 647–54
   PubMed Web of Science ®Google Scholar
• Caliskan E, Kilic T, Bodur H, Zeteroglu S. The frequency of metabolic syndrome in women with polycystic ovaries at reproductive age and comparison of different diagnostic criteria for metabolic syndrome. J Turkish-German Gynecol Assoc. 2007; 8: 402–7
   Google Scholar
• Dale PO, Tanbo T, Vaaler S, Abyholm T. Body weight, hyperinsulinemia, and gonadotropin levels in the polycystic ovarian syndrome: evidence of two distinct populations. Fertil Steril. 1992; 58: 487–91
   PubMed Web of Science ®Google Scholar
• Meirow D, Yossepowitch O, Rösler A, Brzezinski A, Schenker JG, Laufer N, et al. Insulin resistant and non-resistant polycystic ovary syndrome represent two clinical and endocrinological subgroups. Hum Reprod. 1995; 10: 1951–6
   PubMed Web of Science ®Google Scholar
• Acién P, Quereda F, Matallín P, Villarroya E, López-Fernández JA, Acién M, et al. Insulin, androgens, and obesity in women with and without polycystic ovary syndrome: a heterogeneous group of disorders. Fertil Steril. 1999; 72: 32–40
   PubMed Web of Science ®Google Scholar
• Ehrmann DA, Schneider DJ, Sobel BE, Cavaghan MK, Imperial J, Rosenfield RL, et al. Troglitazone improves defects in insulin action, insulin secretion, ovarian steroidogenesis, and fibrinolysis in women with polycystic ovary syndrome. J Clin Endocrinol Metab. 1997; 82: 2108–16
   PubMed Web of Science ®Google Scholar
• Morin-Papunen LC, Koivunen RM, Ruokonen A, Martikainen HK. Metformin therapy improves the menstrual pattern with minimal endocrine and metabolic effects in women with polycystic ovary syndrome. Fertil Steril. 1998; 69: 691–6
   PubMed Web of Science ®Google Scholar
• Nestler JE, Jakubowicz DJ. Lean women with polycystic ovary syndrome respond to insulin reduction with decreases in ovarian P450c17 alpha activity and serum androgens. J Clin Endocrinol Metab. 1997; 82: 4075–9
   PubMed Web of Science ®Google Scholar
• Checa MA, Requena A, Salvador C, Tur R, Callejo J, Espinós JJ, et al. Reproductive Endocrinology Interest Group of the Spanish Society of Fertility. Insulin-sensitizing agents: use in pregnancy and as therapy in polycystic ovary syndrome. Hum Reprod Update. 2005; 11: 375–90
   PubMed Web of Science ®Google Scholar
• Onalan G, Goktolga U, Ceyhan T, Bagis T, Onalan R, Pabuçcu R. Predictive value of glucose-insulin ratio in PCOS and profile of women who will benefit from metformin therapy: obese, lean, hyper or normoinsulinemic?. Eur J Obstet Gynecol Reprod Biol. 2005; 123: 204–11
   PubMed Web of Science ®Google Scholar
• Tan S, Hahn S, Benson S, Dietz T, Lahner H, Moeller LC, et al. Metformin improves polycystic ovary syndrome symptoms irrespective of pre-treatment insulin resistance. Eur J Endocrinol. 2007; 157: 669–76
   PubMed Web of Science ®Google Scholar
• Trolle B, Flyvbjerg A, Kesmodel U, Lauszus FF. Efficacy of metformin in obese and non-obese women with polycystic ovary syndrome: a randomized, double-blinded, placebo-controlled cross-over trial. Hum Reprod. 2007; 22: 2967–73
   PubMed Web of Science ®Google Scholar
• Thessaloniki ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Consensus on infertility treatment related to polycystic ovary syndrome. Fertil Steril. 2008;89:505–22.
   PubMed Web of Science ®Google Scholar
• Nestler JE. Metformin in the treatment of infertility in PCOS: an alternative perspective. Fertil Steril. 2008; 90: 14–6
   PubMed Web of Science ®Google Scholar
• Stadtmauer LA, Wong BC, Oehninger S. Should patients with polycystic ovary syndrome be treated with metformin? Benefits of insulin sensitizing drugs in polycystic ovary syndrome – beyond ovulation induction. Hum Reprod. 2002; 17: 3016–26
   PubMed Web of Science ®Google Scholar
• Moll E, Bossuyt PM, Korevaar JC, Lambalk CB, van der Veen F. Effect of clomifene citrate plus metformin and clomifene citrate plus placebo on induction of ovulation in women with newly diagnosed polycystic ovary syndrome: randomised double blind clinical trial. BMJ. 2006; 332: 1485–1489
   PubMed Web of Science ®Google Scholar
• Legro RS, Barnhart HX, Schlaff WD, Carr BR, Diamond MP, Carson SA, et al. Clomiphene, metformin, or both for infertility in the polycystic ovary syndrome. N Engl J Med. 2007; 356: 551–66
   PubMed Web of Science ®Google Scholar
• Stadtmauer LA, Toma SK, Riehl RM, Talbert LM. Metformin treatment of patients with polycystic ovary syndrome undergoing in vitro fertilization improves outcomes and is associated with modulation of the insulin-like growth factors. Fertil Steril. 2001; 75: 505–9
   PubMed Web of Science ®Google Scholar
• Kjøtrød SB, von Düring V, Carlsen SM. Metformin treatment before IVF/ICSI in women with polycystic ovary syndrome: a prospective, randomized, double blind study. Hum Reprod. 2004; 19: 1315–22
   PubMed Web of Science ®Google Scholar
• Doldi N, Persico P, Di Sebastiano F, Marsiglio E, Ferrari A. Gonadotropin-releasing hormone antagonist and metformin for treatment of polycystic ovary syndrome patients undergoing in vitro fertilization-embryo transfer. Gynecol Endocrinol. 2006; 22: 235–8
   PubMed Web of Science ®Google Scholar
• Tang T, Glanville J, Orsi N, Barth JH, Balen AH. The use of metformin for women with PCOS undergoing IVF treatment. Hum Reprod. 2006; 21: 1416–25
   PubMed Web of Science ®Google Scholar
• Costello MF, Chapman M, Conway U. A systematic review and meta-analysis of randomized controlled trials on metformin co-administration during gonadotrophin ovulation induction or IVF in women with polycystic ovary syndrome. Hum Reprod. 2006; 21: 1387–99
   PubMed Web of Science ®Google Scholar
• Moll E, van der Veen F, van Wely M. The role of metformin in polycystic ovary syndrome: a systematic review. Hum Reprod Update. 2007; 13: 527–37
   PubMed Web of Science ®Google Scholar
• Jakubowicz DJ, Iuorno MJ, Jakubowicz S, Roberts KA, Nestler JE. Effects of metformin on early pregnancy loss in the polycystic ovary syndrome. J Clin Endocrinol Metab. 2002; 87: 524–9
   PubMed Web of Science ®Google Scholar
• Khattab S, Mohsen IA, Foutouh IA, Ramadan A, Moaz M, Al-Inany H. Metformin reduces abortion in pregnant women with PCOS. Gynecol Endocrinol. 2006; 22: 680–4
   PubMed Web of Science ®Google Scholar
• Thatcher SS, Jackson EM. Pregnancy outcome in infertile patients with PCOS who were treated with metformin. Fertil Steril. 2006; 85: 1002–9
   PubMed Web of Science ®Google Scholar